Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal Journal of Education Technology Information Social Sciences and Health
Nurhayati
Harapan Ibu School of Health Sciences
Computer Science & IT Education Neuroscience Nursing Public Health

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Analysis of Potential Antiretroviral Drug Interactions Among HIV Patients at Puskesmas X, Jambi City, in 2025 Junita Anggi Rahmawati; Jelly Permatasari; Nurhayati
Journal of Education Technology Information Social Sciences and Health Vol. 5 No. 2 (2026): September 2026
Publisher : CV. Rayyan Dwi Bharata

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.57235/jetish.v5i2.9130

Abstract

Introduction: Human Immunodeficiency Virus (HIV) infection requires continuous antiretroviral (ARV) therapy involving the use of multiple medications. Such combination therapy may increase the risk of drug interactions, which may potentially affect the efficacy and safety of treatment. Methods: This study employed a non-experimental study design with a descriptive approach and retrospective design. The study data were obtained from secondary data in the form of HIV patient visit records. A total of 72 patients were selected using purposive sampling. Potential drug interactions were identified using Drugs.com, Medscape, and DrugBank, and the data were analyzed descriptively using Microsoft Excel 2021. Results: The majority of patients were in the young adult age group (26–35 years), comprising 27 patients (37.50%), and most were male, with 62 patients (86.11%). The most frequently used ARV regimen was a combination of tenofovir disoproxil fumarate (TDF), lamivudine (3TC), and dolutegravir (DTG), used by 63 patients (87.50%). A total of 18 potential drug interactions were identified, predominantly involving pharmacodynamic mechanisms, accounting for 17 cases (94.44%), while pharmacokinetic interactions accounted for 1 case (5.56%). Regarding severity, 17 cases (94.44%) were classified as moderate and 1 case (5.56%) as major, with no minor interactions identified. Conclusion: Potential ARV drug interactions among HIV patients at Puskesmas X, Jambi City, in 2025 were predominantly pharmacodynamic in mechanism and moderate in severity.
Co-Authors Jelly Permatasari Junita Anggi Rahmawati